Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1073726 10.3389/fphar.2022.1073726 Pharmacology Correction Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury Irrera et al. 10.3389/fphar.2022.1073726 Irrera Natasha 1 Arcoraci Vincenzo 1 Mannino Federica 1 Vermiglio Giovanna 2 Pallio Giovanni 1 Minutoli Letteria 1 Bagnato Gianluca 3 Anastasi Giuseppe Pio 2 Mazzon Emanuela 4 Bramanti Placido 4 Squadrito Francesco 1 * Altavilla Domenica 2 Bitto Alessandra 1 1 Department of Clinical and Experimental Medicine, AOU Policlinico G. Martino, University of Messina, Messina, Italy 2 Department of Biomedical and Dental Sciences and Morphological and Functional Sciences, AOU Policlinico G. Martino, University of Messina, Messina, Italy 3 NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom 4 IRCCS Centro Neurolesi “Bonino-Pulejo”, Messina, Italy *Correspondence: Francesco Squadrito, fsquadrito@unime.it

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology

 03 11 2022 2022 13 1073726 18 10 2022 03 11 2022 Copyright © 2022 Irrera, Arcoraci, Mannino, Vermiglio, Pallio, Minutoli, Bagnato, Anastasi, Mazzon, Bramanti, Squadrito, Altavilla and Bitto. 2022 Irrera, Arcoraci, Mannino, Vermiglio, Pallio, Minutoli, Bagnato, Anastasi, Mazzon, Bramanti, Squadrito, Altavilla and Bitto

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury by Irrera N, Arcoraci V, Mannino F, Vermiglio G, Pallio G, Minutoli L, Bagnato G, Anastasi GP, Mazzon E, Bramanti P, Squadrito F, Altavilla D and Bitto A (2018). Front. Pharmacol. 9:506. doi: 10.3389/fphar.2018.00506 adenosine receptors inflammation neurogenesis polydeoxyribonucleotide spinal cord injury

In the published article, the Conflict of interest statement was incorrect. The correct Conflict of interest statement appears below:

Conflict of interest

“The author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease. Author LM, FS and AB are co-inventor on a patent describing therapeutic polydeoxyribonucleotide activity in testicular injury by torsion.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest”.

The authors apologize for this error and state that this does not change the scientific conclusion of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.